Skip to main content

Agora
Sign in

House bill · H.R. 1796 (119th Congress)

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

U.S. House of Representatives

Latest action Mar 3, 2025

Sponsor: John James (U.S. Representative, MI-10, Republican)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

Would amend the Public Health Service Act to reauthorize the sickle cell disease demonstration program and extend its scope to cover the prevention and treatment of complications of sickle cell disease.

AI summary. Not an official summary. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Cosponsors

6

Cosponsors listed on Congress.gov, shown A to Z.

  • Democratic5
  • Republican1

This bill has cosponsors from more than one party.

Shown in neutral colors by design; Agora is non-partisan.

Related bills

As identified by Congress.gov.

Full history

  1. Mar 3, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  2. Mar 3, 2025

    Introduced

    Introduced in U.S. House

    U.S. House

  3. Mar 3, 2025

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House of Representatives

Read the record